Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
208.61B
Market cap208.61B
Price-Earnings ratio
11.51
Price-Earnings ratio11.51
Dividend yield
2.61%
Dividend yield2.61%
Average volume
17.18M
Average volume17.18M
High today
$46.70
High today$46.70
Low today
$45.57
Low today$45.57
Open price
$45.87
Open price$45.87
Volume
9.56M
Volume9.56M
52 Week high
$64.16
52 Week high$64.16
52 Week low
$35.12
52 Week low$35.12

NVO News

CNBC 6h
Novo Nordisk CEO Mike Doustdar sits down with Jim Cramer - CNBC

...

Novo Nordisk CEO Mike Doustdar sits down with Jim Cramer - CNBC
Simply Wall St 10h
Novo Nordisk Stock Still Looks Cheap On Earnings But Faces Growth Doubts

Novo Nordisk stock has pulled back sharply over the last three years, yet the company still screens as attractively valued on several checks. Recent news on obe...

Novo Nordisk Stock Still Looks Cheap On Earnings But Faces Growth Doubts
Nasdaq 1d
Novo Nordisk Stock: Buy or Sell?

The company reported quarterly financial results, which have implications for shareholders. Where to invest $1,000 right now? Our analyst team just revealed wh...

Novo Nordisk Stock: Buy or Sell?

Analyst ratings

57%

of 37 ratings
Buy
35.1%
Hold
56.8%
Sell
8.1%

More NVO News

Nasdaq 1d
Better Buy: Eli Lilly vs. Novo Nordisk

Key Points Eli Lilly has a stronger GLP-1 portfolio and pipeline than Novo Nordisk. Eli Lilly also has a better lineup outside the diabetes and weight-loss ar...

Better Buy: Eli Lilly vs. Novo Nordisk
TipRanks 2d
Novo Nordisk’s New Obesity Metabolism Trial: What Investors Should Watch

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident i...

Nasdaq 2d
NVO Crosses Above Average Analyst Target

In recent trading, shares of Novo-Nordisk AS (Symbol: NVO) have crossed above the average analyst 12-month target price of $47.48, changing hands for $47.73/sha...

NVO Crosses Above Average Analyst Target
The Motley Fool 2d
Why Eli Lilly Topped the Market Today

Eli Lilly (LLY +3.90%) had a fine start to the trading week. On Monday, its stock rose by almost 4% on news that a key European regulator had approved one of it...

Why Eli Lilly Topped the Market Today
TipRanks 3d
Novo Nordisk Expands Treasury Position as 2026 Share Buyback Nears DKK 8 Billion

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Simply Wall St 6d
Novo Nordisk Faces A Fair Value Debate, Is It Still 55% Undervalued?

Novo Nordisk (NYSE:NVO) has drawn fresh attention after recent share price moves, with the stock closing at US$45.97. Investors are weighing this level against...

Novo Nordisk Faces A Fair Value Debate, Is It Still 55% Undervalued?
TipRanks 7d
Retail Investors Send in Sick Note for HIMS Stock Ahead of Q2 Earnings

Retail investors are feeling less healthy about the prospects of Hims & Hers (HIMS) as it gets set to report Q2 earnings next week – August 10th. Unlock powerf...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.